CG:600713 NanJing Pharmaceutical Company Limited

Nanjing Pharmaceutical Company Limited is principally engaged in manufacture and distribution of Chinese medicines and western drugs. The Company operates its businesses primarily through pharmaceutical distribution, which involves in operation of regular chain drug stores, delivery of pharmaceuticals, supply chain management and logistics services, among others; pharmaceutical production, which offers Chinese patent medicines, tablets, capsules, granules, solvents and bulk drugs, among others, as well as asset management business, which includes credit guarantee, international trading, hotel services and information services. The Company operates its businesses primarily in domestic market.

4.93 CNY
As of 01/17/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Unknown
Industry:  Drug Manufacturers-General
Index country:  China
Country of incorporation:  China
IPO date:  01/03/2000
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   5,135,137,280 CNY
Current dividend yield:   2.23%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy